Regulation of bone metabolism mediated by β-adrenergic receptor and its clinical application
Authors:
- Xue-Ping ZhongXZXue-Ping Zhong
- Wen-Fang XiaWXWen-Fang Xia
Open Access
- 26 October 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 9 (30) , 8967-8973
Abstract
Recent studies have confirmed that β-adrenergic receptors (β-ARs) are expressed on the surface of osteoblasts and osteoclasts, and that the sympathetic nervous system can regulate bone metabolism by activating them. β-AR blockers (BBs) are commonly used in the treatment of cardiovascular diseases in the elderly. It is important to investigate whether BBs have a beneficial effect on bone metabolism in the treatment of cardiovascular diseases, so as to expand their clinical application. This article reviews the effects of BB on bone metabolism and the progress of clinical research.Keywords
This publication has 38 references indexed in Scilit:
- Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by19F-NMRScience, 2012
- Low dose of propranolol down‐modulates bone resorption by inhibiting inflammation and osteoclast differentiationBritish Journal of Pharmacology, 2011
- Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrualJournal of Experimental Medicine, 2011
- Association between beta-blocker use and fracture risk: The Dubbo Osteoporosis Epidemiology StudyBone, 2011
- β2- and β3-, but not β1-adrenergic receptors are involved in osteogenesis of mouse mesenchymal stem cells via cAMP/PKA signalingArchives of Biochemistry and Biophysics, 2010
- When 7 transmembrane receptors are not G protein-coupled receptorsJournal of Clinical Investigation, 2005
- Leptin regulation of bone resorption by the sympathetic nervous system and CARTNature, 2005
- β-Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis StudyJournal of Bone and Mineral Research, 2004
- Effects of β-adrenergic agonists on bone-resorbing activity in human osteoclast-like cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2003
- Formoterol and Isoproterenol Induce c-fos Gene Expression in Osteoblast-Like Cells by Activating β2-Adrenergic ReceptorsBone, 1998